Lataa...
Comparative effectiveness of an angiotensin receptor blocker, olmesartan medoxomil, in older hypertensive patients
The efficacy and safety of olmesartan medoxomil (OM) vs active control (AC) monotherapy among elderly patients aged 60‐79 years (N = 4487) was evaluated by meta‐analysis (25 studies). In all patients, change from baseline to end point in blood pressure (BP) was significantly greater with OM vs AC (−...
Tallennettuna:
| Julkaisussa: | J Clin Hypertens (Greenwich) |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8031060/ https://ncbi.nlm.nih.gov/pubmed/29462508 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jch.13183 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|